Literature DB >> 25979827

Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2.

Stephen G Dann1, Michael Ryskin2, Anthony M Barsotti2, Jonathon Golas2, Celine Shi2, Miriam Miranda2, Christine Hosselet2, Luanna Lemon2, Judy Lucas2, Maha Karnoub3, Fang Wang2, Jeremy S Myers2, Scott J Garza4, Maximillian T Follettie2, Kenneth G Geles2, Anke Klippel3, Robert A Rollins2, Valeria R Fantin4.   

Abstract

Lat1 (SLC7A5) is an amino acid transporter often required for tumor cell import of essential amino acids (AA) including Methionine (Met). Met is the obligate precursor of S-adenosylmethionine (SAM), the methyl donor utilized by all methyltransferases including the polycomb repressor complex (PRC2)-specific EZH2. Cell populations sorted for surface Lat1 exhibit activated EZH2, enrichment for Met-cycle intermediates, and aggressive tumor growth in mice. In agreement, EZH2 and Lat1 expression are co-regulated in models of cancer cell differentiation and co-expression is observed at the invasive front of human lung tumors. EZH2 knockdown or small-molecule inhibition leads to de-repression of RXRα resulting in reduced Lat1 expression. Our results describe a Lat1-EZH2 positive feedback loop illustrated by AA depletion or Lat1 knockdown resulting in SAM reduction and concomitant reduction in EZH2 activity. shRNA-mediated knockdown of Lat1 results in tumor growth inhibition and points to Lat1 as a potential therapeutic target.
© 2015 The Authors.

Entities:  

Keywords:  SLC7A5; S‐adenosylmethionine; cancer metabolism; methionine cycle

Mesh:

Substances:

Year:  2015        PMID: 25979827      PMCID: PMC4516430          DOI: 10.15252/embj.201488166

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  25 in total

1.  Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression.

Authors:  Daniel R Rhodes; Jianjun Yu; K Shanker; Nandan Deshpande; Radhika Varambally; Debashis Ghosh; Terrence Barrette; Akhilesh Pandey; Arul M Chinnaiyan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

2.  Control of developmental regulators by Polycomb in human embryonic stem cells.

Authors:  Tong Ihn Lee; Richard G Jenner; Laurie A Boyer; Matthew G Guenther; Stuart S Levine; Roshan M Kumar; Brett Chevalier; Sarah E Johnstone; Megan F Cole; Kyo-ichi Isono; Haruhiko Koseki; Takuya Fuchikami; Kuniya Abe; Heather L Murray; Jacob P Zucker; Bingbing Yuan; George W Bell; Elizabeth Herbolsheimer; Nancy M Hannett; Kaiming Sun; Duncan T Odom; Arie P Otte; Thomas L Volkert; David P Bartel; Douglas A Melton; David K Gifford; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

3.  Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.

Authors:  Brian Z Ring; Robert S Seitz; Rod Beck; William J Shasteen; Shannon M Tarr; Maggie C U Cheang; Brian J Yoder; G Thomas Budd; Torsten O Nielsen; David G Hicks; Noel C Estopinal; Douglas T Ross
Journal:  J Clin Oncol       Date:  2006-07-01       Impact factor: 44.544

4.  Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA.

Authors:  Syuzo Kaneko; Gang Li; Jinsook Son; Chong-Feng Xu; Raphael Margueron; Thomas A Neubert; Danny Reinberg
Journal:  Genes Dev       Date:  2010-12-01       Impact factor: 11.361

5.  The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.

Authors:  Mirjam T Epping; Liming Wang; Michael J Edel; Leone Carlée; Maria Hernandez; René Bernards
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

6.  c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism.

Authors:  Ping Gao; Irina Tchernyshyov; Tsung-Cheng Chang; Yun-Sil Lee; Kayoko Kita; Takafumi Ochi; Karen I Zeller; Angelo M De Marzo; Jennifer E Van Eyk; Joshua T Mendell; Chi V Dang
Journal:  Nature       Date:  2009-02-15       Impact factor: 49.962

7.  Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.

Authors:  H Y Lee; M I Dawson; G L Walsh; J C Nesbitt; R L Eckert; E Fuchs; W K Hong; R Lotan; J M Kurie
Journal:  Cell Growth Differ       Date:  1996-08

8.  Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family.

Authors:  L Mastroberardino; B Spindler; R Pfeiffer; P J Skelly; J Loffing; C B Shoemaker; F Verrey
Journal:  Nature       Date:  1998-09-17       Impact factor: 49.962

9.  ATP-citrate lyase links cellular metabolism to histone acetylation.

Authors:  Kathryn E Wellen; Georgia Hatzivassiliou; Uma M Sachdeva; Thi V Bui; Justin R Cross; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

10.  Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer.

Authors:  K Kaira; N Oriuchi; H Imai; K Shimizu; N Yanagitani; N Sunaga; T Hisada; S Tanaka; T Ishizuka; Y Kanai; H Endou; T Nakajima; M Mori
Journal:  Br J Cancer       Date:  2008-02-05       Impact factor: 7.640

View more
  26 in total

Review 1.  Nuclear metabolism and the regulation of the epigenome.

Authors:  Ruben Boon; Giorgia G Silveira; Raul Mostoslavsky
Journal:  Nat Metab       Date:  2020-10-12

2.  Lipids Reprogram Metabolism to Become a Major Carbon Source for Histone Acetylation.

Authors:  Eoin McDonnell; Scott B Crown; Douglas B Fox; Betül Kitir; Olga R Ilkayeva; Christian A Olsen; Paul A Grimsrud; Matthew D Hirschey
Journal:  Cell Rep       Date:  2016-11-01       Impact factor: 9.423

Review 3.  Attacking the supply wagons to starve cancer cells to death.

Authors:  Elizabeth M Selwan; Brendan T Finicle; Seong M Kim; Aimee L Edinger
Journal:  FEBS Lett       Date:  2016-03-22       Impact factor: 4.124

Review 4.  Metabolic signatures of cancer cells and stem cells.

Authors:  Andrew M Intlekofer; Lydia W S Finley
Journal:  Nat Metab       Date:  2019-02-11

Review 5.  MicroRNA-7: a promising new target in cancer therapy.

Authors:  Juanjuan Zhao; Yijing Tao; Ya Zhou; Nalin Qin; Chao Chen; Dan Tian; Lin Xu
Journal:  Cancer Cell Int       Date:  2015-10-29       Impact factor: 5.722

6.  Epigenomic profiling of preterm infants reveals DNA methylation differences at sites associated with neural function.

Authors:  S Sparrow; J R Manning; J Cartier; D Anblagan; M E Bastin; C Piyasena; R Pataky; E J Moore; S I Semple; A G Wilkinson; M Evans; A J Drake; J P Boardman
Journal:  Transl Psychiatry       Date:  2016-01-19       Impact factor: 6.222

7.  Methylmercury Uptake into BeWo Cells Depends on LAT2-4F2hc, a System L Amino Acid Transporter.

Authors:  Christina Balthasar; Herbert Stangl; Raimund Widhalm; Sebastian Granitzer; Markus Hengstschläger; Claudia Gundacker
Journal:  Int J Mol Sci       Date:  2017-08-08       Impact factor: 5.923

Review 8.  The Human SLC7A5 (LAT1): The Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health.

Authors:  Mariafrancesca Scalise; Michele Galluccio; Lara Console; Lorena Pochini; Cesare Indiveri
Journal:  Front Chem       Date:  2018-06-22       Impact factor: 5.221

Review 9.  Cysteine as a Carbon Source, a Hot Spot in Cancer Cells Survival.

Authors:  Jacinta Serpa
Journal:  Front Oncol       Date:  2020-06-23       Impact factor: 6.244

Review 10.  Metabolic regulation of chromatin modifications and gene expression.

Authors:  Juan Manuel Schvartzman; Craig B Thompson; Lydia W S Finley
Journal:  J Cell Biol       Date:  2018-05-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.